Biofrontera May Be A $40+ Stock In The Short-Term, But Its Strong Fundamentals Make The Company A Fit For The Long-Term Investor Too
Published on: Thursday 23 December 2021
Specifically, CEO Erica Monaco, during the last earnings call, was quoted as saying, "We have enough funds to last the ... advisor prior to making any investment decisions.